News for Palatin Technologies, Inc. - Google Finance

Palatin Technologies, Inc. (PTN) Reports Q1 Loss of $0.04; Updates ...

Tue, 14 May 2013 11:38:22 GMT

Palatin Technologies, Inc. (PTN) Reports Q1 Loss of $0.04; Updates ...
StreetInsider.com (subscription) - May 14, 2013

Palatin Technologies, Inc. (PTN) Reports Q1 Loss of $0.04; Updates Bremelanotide Development. Article Related Press Releases (1) Stock Quotes (1) Comments (0).

Palatin Technologies (PTN) Announces Quarterly Results - The Utah People's Post

PALATIN TECHNOLOGIES, INC. : Palatin Technologies Announces Third ...

Tue, 14 May 2013 13:02:37 GMT

PALATIN TECHNOLOGIES, INC. : Palatin Technologies Announces Third ...
4-traders (press release) - May 14, 2013

PRINCETON, NJ (February 15, 2002) - Palatin Technologies Inc (AMEX:PTN) today announced results for its second quarter ended December 31, 2001.

Palatin Technologies, Inc. To Report Fiscal Year 2013 Third Quarter Results ...

Wed, 08 May 2013 14:21:08 GMT

Palatin Technologies, Inc. To Report Fiscal Year 2013 Third Quarter Results ...
Sacramento Bee - May 8, 2013

About Palatin Technologies, Inc. Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.

This Metric Says You Are Smart to Buy Palatin Technologies, Inc. (PTN)

Sun, 28 Apr 2013 17:22:41 GMT

This Metric Says You Are Smart to Buy Palatin Technologies, Inc. (PTN)
Insider Monkey (blog) - Apr 28, 2013

Is Palatin Technologies, Inc. (NYSEAMEX:PTN) undervalued? Investors who are in the know are becoming hopeful. The number of long hedge fund bets rose by 1 lately.

Palatin Technologies Announces Notification of Patent Allowance On ...

Thu, 02 May 2013 11:32:02 GMT

Palatin Technologies Announces Notification of Patent Allowance On ...
PR Newswire (press release) - May 2, 2013

CRANBURY, N.J., May 2, 2013 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and ...

Palatin Technologies Q3 13 Earnings Conference Call At 11:00 AM ET

Tue, 14 May 2013 14:08:33 GMT

Palatin Technologies Q3 13 Earnings Conference Call At 11:00 AM ET
NASDAQ - May 14, 2013

(RTTNews.com) - Palatin Technologies Inc.( PTN ) will host a conference call at 11:00 AM ETMay 14, 2013, to discuss its Q3 13 earnings results.

Exide Technologies (NASDAQ:XIDE) down by 9.94%, Primo Water Corporation ...

Thu, 02 May 2013 17:54:07 GMT

Exide Technologies (NASDAQ:XIDE) down by 9.94%, Primo Water Corporation ...
NIS - May 2, 2013

New York, NY - (NISMAGAZINE) - 05/02/2013- Exide Technologies (NASDAQ:XIDE) shares decreased 9.94% to $0.713 from its previous close of $0.79.

US/Canada daily earnings hits & misses May 14 - 1800 ET

Tue, 14 May 2013 12:01:33 GMT

US/Canada daily earnings hits & misses May 14 - 1800 ET
Reuters - May 14, 2013

... 0.00 -0.02 -0.02 26.2 23.7 -2.5 PALATIN TECHNOLOGIES INC Q3 LEISURE USD -0.06 -0.04 0.02 0.0 0.0 0.0 PAN AMERICAN SILVER CORP Q1 PRECIOUS METALS USD 0.24 0.26 0.02 260.3 243.0 -17.3 PAN AMERICAN SILVER CORP Q1 PRECIOUS ...

Earnings Scheduled For May 14, 2013

Tue, 14 May 2013 09:17:05 GMT

Earnings Scheduled For May 14, 2013
Benzinga - May 14, 2013

Opexa Therapeutics Inc. (NASDAQ: OPXA) is expected to post its earnings report today. Palatin Technologies, Inc. (NYSE: PTN) is estimated to post its Q3 earnings at $0.05 per share.

Pre-Market Earnings Report for May 14, 2013 : VAL, PAAS, GSOL, BRD, GFN ...

Mon, 13 May 2013 20:15:51 GMT

Pre-Market Earnings Report for May 14, 2013 : VAL, PAAS, GSOL, BRD, GFN ...
NASDAQ - May 13, 2013

Palatin Technologies, Inc. ( PTN ) is reporting for the quarter ending March 31, 2013. The consensus earnings per share forecast from the 2 analysts that follow the stock is $-0.05.